Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Dublin, Nov. 15, 2024 (GLOBE NEWSWIRE) -- The "Airlines Global Industry Guide 2019-2028" report has been added to ResearchAndMarkets.com's offering.Global Airlines industry profile provides...
-
Topline data from Phase 2 CM24 pancreatic cancer trial expected by the end of 2024 New CM24 biomarkers data presented during the third quarter of 2024 including two predicting serum biomarkers...
-
Singapore, Nov. 14, 2024 (GLOBE NEWSWIRE) -- What is AVATAR and what does it solve? Avatar Social is a next-generation social platform designed to centralize various digital activities within a...
-
Greensboro, NC, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Hundreds of children in foster care will have a special holiday this year because of community support for Hope for the Holidays, led by Children’s...
-
New York, United States, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Target drones are a subclass of remote-controlled unmanned aerial vehicles (UAVs) used for testing and evaluating armament systems,...
-
TORONTO, 14 nov. 2024 (GLOBE NEWSWIRE) -- La Société canadienne de la SLA est fière d'annoncer le premier conseiller national en génétique du Canada, qui a pour mission soutenir les personnes...
-
TORONTO, Nov. 14, 2024 (GLOBE NEWSWIRE) -- The ALS Society of Canada (ALS Canada) is proud to announce Canada’s first National Genetic Counsellor dedicated to supporting people affected by...
-
LONDON, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Recently, on 24th October 2024, the Parliamentary Society for Arts and Fashion held its annual Assembly at the House of Parliament, bringing together...
-
Dublin, Nov. 13, 2024 (GLOBE NEWSWIRE) -- The "Battery Management System (BMS) Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application" report...
-
Oral presentation shares head-to-head results for investigational combination pozelimab plus cemdisiran vs. ravulizumab in paroxysmal nocturnal hemoglobinuria Initial results for odronextamab in...